Notably, in Patient 3, both KRAS and BRAF variants were detected in cfDNA, but the same BRAF variant was also identified at a slightly higher VAF in PBMC genomic DNA, suggesting a CH-related origin rather than AVM association. This evidence concerns the gene BRAF and cyclic hematopoiesis.